Ezetimibe BE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-09-30 17:26 (1270 d 01:12 ago) – Posting: # 20657
Views: 3,784

Hi ElMaestro,

❝ "The applicant should document that the enzymatic de-conjugation can be considered quantitative under assay conditions"


:-D:vomit:


That would be a valid request. Has to be determined in method development & validation. No big deal, since β-glucuronidase is used for decades.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,548 posts in 4,723 threads, 1,606 registered users;
22 visitors (0 registered, 22 guests [including 11 identified bots]).
Forum time: 17:38 CET (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5